Whether helping innovators develop ideas or guiding the patent process, UVA partners with faculty, entrepreneurs and investors to bring world-changing ideas from the University into the marketplace.
Researchers at UVA are bringing industry partners to the table to create cutting-edge technologies that produce tangible value for society. At the Multifunctional Integrated System Technology Center (MIST) site in Charlottesville, researchers are helping indsutry solve practical problems and enhancing professional development opportunities for students.
ITHRIV includes the University of Virginia, Inova Health System, Virginia Tech and Carilion Clinic as partners, with the Center for Open Science and UVA’s Licensing & Ventures Group as affiliates. The focus of iTHRIV is “using data to improve health” and leverages the data science expertise across the state.
University of Virginia School of Medicine professor Lee Ritterband created SHUTi (Sleep Healthy Using the Internet) – a digital therapeutic that uses cutting-edge technology to administer cognitive behavioral therapy for people suffering from insomnia. Ritterband's goal is to increase access to effective and affordable behavioral health care
Local biotechnology industry leader Nikki Hastings, PhD, has been named the first Executive Director of the CvilleBioHub, a non-profit that connects and supports the Charlottesville-area biotechnology sector. CvilleBioHub will receive strategic planning assistance from Denise Hubbard, program director for UVA’s Office of Economic Development, and Grant Tate, of the Bridge Ltd. consulting firm.
The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners.
PsiKick is utilizing revolutionary ultra-low-power technologies from the Universities of Virginia and Michigan to build completely self-powered sensing systems that do not require batteries, can be deployed nearly anywhere, and unlock new data streams that generate significant value in Virginia and beyond. The company also creates jobs in the Charlottesville region.
A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia. Grounded in UVA research and support from UVA's Licensing and Ventures Group (LVG), companies like Contraline and TearSolutions are making exciting advances and nurturing the biotechnology ecosystem in the region.
Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG). Now, LVG has exited from TypeZero following acquisition by DexCom, the leader in continuous glucose monitoring for diabetes. The news highlights UVA's cultivation of research and entrepreneurship that ultimately improves lives and stimulates our economy.
The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc. all have the potential to make an impact and to drive the local and regional economy. The LVG Seed Fund offers UVA-affiliated startups capital to advance opportunities often considered too early for investment by traditional sources.
Mission Secure Inc. recently announced the closing of an $8 million Series A financing round led by Energy Innovation Capital and Chevron Technology Ventures. The company spun out of UVA research and intellectual property developed by UVA's Licensing and Ventures Group. Mission Secure Inc. supports jobs in Charlottesville and plans to double their workforce going forward.
NSF funding will allow UVA Engineering’s Link Lab to develop a new program that will train graduate students to make discoveries and then translate that knowledge into new technologies, products and services. The program will help train the next generation of scientific leaders to develop the skills necessary to tackle complex societal problems.
Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia. He will oversee programs and facilities currently offered by Darden, the McIntire School of Commerce, and the School of Continuing and Professional Studies, among others. His appointment is indicative of UVA's growing presence in the Washington region.